Date : 27 April 2026

| Companies | Headquarters | Outpatient & Home Infusion Services |
| Option Care Health | Bannockburn, U.S | Home Infusion Plus |
| Baxter International | Deerfield, U.S. | Infusion Therapies and Technologies |
| CVS Health | Denver, U.S. | Coram CVS Specialty Infusion Services |
| B. Braun Melsungen | Melsungen, Germany | Outpatient Services |
| UnitedHealth Group | Minnetonka, U.S. | Optum Infusion Pharmacy |
| Fresenius Kabi | Bad Homburg, Germany | Aglilia |
| Elevance Health | Plano, U.S. | Paragon Healthcare |
| KabaFusion | Cerritos, U.S. | KabaFusion |
| Cigna | Memphis, U.S | Accredo Specialty Pharmacy |
| Amedisys | Baton Rouge, U.S. | Contessa Health |
R&D
Clinical Trials and Regulatory Approvals
Patient Support and Services
The global outpatient & home infusion services market size was estimated at USD 10.78 billion in 2025 and is predicted to increase from USD 11.78 billion in 2026 to approximately USD 26.09 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035. The growing chronic disease burden globally is increasing the use of outpatient & home infusion services. Growing shift towards home-based care, expanding specialist therapies, technological advancements, investments, and new product launches are also enhancing the market growth.

Speak with a healthcare analyst about your research, consulting, or platform needs.